Natco Pharma has received successful Establishment Inspection Report (EIR) during the period February 29 to March 7, 2016 from the U.S. Food and Drug Administration (USFDA) for the inspection conducted at its drug manufacturing facility in Kothur Village, Mahaboob Nagar District, India. The Kothur facility predominantly caters to regulated international markets, including USA.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.
